SIRT2 and non-small cell lung carcinoma: For instance, there is a correlation between upregulation of SIRT2 with malignancy progression in hepatocellular carcinoma (HCC) and NSCLC.[14, 44, 45] On the contrary, there is also evidence to support that SIRT2 deficiency in mice causes tumorigenesis in mammary tumors and HCC.